Dose and time dependent changes in plasma ptau181 in patients treated with aducanumab in the ENGAGE and EMERGE trials at CTAD
Nov 11, 2021 5:10 PM EST
Events & Presentations
Event Details
Stockholder Communications
E-mail Alerts
FAQs